GSK (GSK) is raising $6.5 billion from a US high-grade debt sale to help refinance bridge funding for its $10.6 billion takeover of Nuvalent, Bloomberg reported, citing people familiar with the matter.
The size of the bond sale is about $500 million more than initial talks, the people reportedly told Bloomberg.
GSK didn't immediately reply to a request for comment from.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: $48.69, Change: $-1.21, Percent Change: -2.42%